Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPB1 | P04792 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5409494 | 0.92 | ALDH1A1 (0.54) | HSPB1CA1CA2CES1CA9 | |
| SCHEMBL23844032 | 0.86 | ALDH1A1 (0.43) | HSPB1CA1CA2CES1CA9 | |
| SCHEMBL10745979 | 0.84 | CA1 (0.50) | HSPB1CA1CA2CES1CA9 | |
| SCHEMBL30777840 | 0.83 | HSPB1 (0.48) | HSPB1CA1CA2CES1CA9 | |
| SCHEMBL15588700 | 0.83 | HSPB1 (0.48) | HSPB1CA1CA2CES1CA9 | |
| SCHEMBL357344 | 0.83 | CA1 (0.52) | HSPB1CA1CA2CES1CA9 | |
| SCHEMBL5712600 | 0.82 | HPGD (0.45) | HSPB1ALDH1A1HSD17B10LMNAMAPK1 | |
| SCHEMBL18476534 | 0.80 | ALOX5 (0.47) | HSPB1ALDH1A1LMNAGAACYP3A4 | |
| SCHEMBL7148173 | 0.80 | PTGS2 (0.40) | HSPB1CA1CA2CES1CA9 | |
| SCHEMBL28803957 | 0.80 | CA1 (0.41) | HSPB1CA1CA2CES1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | UNIV NORTHWESTERN (US) | 2025-10-23 | — | — | US | claimed |
| WO-2024025604-A9 | DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY | NORTHWESTERN UNIVERSITY (US) | 2024-05-02 | — | — | WO | claimed |
| WO-2024025604-A2 | DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY | NORTHWESTERN UNIVERSITY (US) | 2024-02-01 | — | — | WO | claimed |
| US-20190161556-A1 | Fusion Protein Construct | NORTHWESTERN UNIVERSITY | 2019-05-30 | — | — | US | claimed |
| EP-3464384-A1 | FUSION PROTEIN CONSTRUCT | Northwestern University (US) | 2019-04-10 | — | — | EP | claimed |
| WO-2017214151-A1 | FUSION PROTEIN CONSTRUCT | NORTHWESTERN UNIVERSITY (US) | 2017-12-14 | — | — | WO | claimed |
| EP-2311939-A1 | Polypeptide immobilization | The University of Chicago (US) | 2011-04-20 | — | — | EP | claimed |
| US-7888055-B2 | Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity | THE UNIVERSITY OF CHICAGO (US) | 2011-02-15 | — | — | US | claimed |
| EP-1196631-A1 | POLYNUCLEOTIDES | Cyclops Genome Sciences Limited (GB) | 2002-04-17 | — | — | EP | claimed |
| WO-2001094626-A1 | POLYNUCLEOTIDES | CYCLOPS GENOME SCIENCES LIMITED (GB) | 2001-12-13 | — | — | WO | claimed |
| WO-2000066605-A2 | POLYNUCLEOTIDES | CYCLOPS GENOME SCIENCES LIMITED (GB) | 2000-11-09 | — | — | WO | claimed |
| US-5272035-A | Photosensitive lithographic printing plate having treated aluminum support with diazonium light-sensitive layer containing polyurethane resin and phosphorous additive | FUJI PHOTO FILM CO., LTD. (JP) | 1993-12-21 | — | — | US | claimed |
| WO-2026101423-A1 | PHOTOSWITCHABLE CHEMICAL INDUCED DIMERIZATION SYSTEMS FOR CONTROL OF CELLULAR ACTIVITIES WITH LIGHT | WU YAOWEN (SE) | 2026-05-15 | — | — | WO | disclosed |
| US-20260063641-A1 | COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS | UNIV UTAH RES FOUND (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | UNIV NORTHWESTERN (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4565594-A2 | COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS | University of Utah Research Foundation (US) | 2025-06-11 | — | — | EP | disclosed |
| CN-86108176-A | Lankacidin derivatives and process for producing the same | — | 1987-10-21 | — | — | CN | disclosed |
| US-4308197-A | POLYIMIDE OR POLYEPOXIDE AND AN AMMONIUM OR AMINE SALT OF AN ORGANIC PHOSPHONIC OR PHOSPHINIC ACID; CHAR STABILITY; AIRCRAFT | MCDONNELL DOUGLAS CORPORATION (US) | 1981-12-29 | — | — | US | disclosed |
| US-4303766-A | SULFONATION OF ELASTOMERS, FRIEDEL-CRAFTS OR COORDINATION CATALYST, ACYL SULFATE, QUENCHING, NEUTRALIZATION | EXXON RESEARCH & ENGINEERING CO. (US) | 1981-12-01 | — | — | US | disclosed |
| US-4105647-A | SOLUTION POLYMERIZATION USING A FRIEDEL-CRAFTS OF ZIEGLER-TYPE CATALYST | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260063641-A1 | COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS | ATIC, JMJD7, UCHL1 | HSPB1 2357/4885CA1 4569/4885CA2 4467/4885 |
| US-20190161556-A1 | Fusion Protein Construct | RPS27A, CD2BP2, JMJD7 | HSPB1 771/4885CA1 1971/4885CA2 2987/4885 |
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | CRABP2, RARB, RARA | HSPB1 2256/4885CA1 1293/4885CA2 620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.